Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...

Background: Symptom control in patients with moderate-to-severe persistent allergic rhinitis (PAR) who remain inadequately controlled on intranasal corticosteroid monotherapy remains challenging, ...

From subway cars to office cubicles, New Yorkers are hoarse and hacking this fall — sidelined by stubborn symptoms that just won’t quit. While official data indicates that overall respiratory illness ...